Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 2
2003 5
2004 14
2005 10
2006 14
2007 12
2008 14
2009 11
2010 13
2011 17
2012 9
2013 4
2014 3
2015 6
2016 6
2017 5
2018 6
2019 3
2020 1
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.
Markou S, Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G. Markou S, et al. Int J Impot Res. 2004 Dec;16(6):470-8. doi: 10.1038/sj.ijir.3901258. Int J Impot Res. 2004. PMID: 15229625 Review.
Trials of the efficacy and safety of vardenafil in the treatment of male erectile dysfunction (ED) were meta-analysed. ...Vardenafil was not significantly associated with serious cardiovascular events or death. ...
Trials of the efficacy and safety of vardenafil in the treatment of male erectile dysfunction (ED) were meta-analysed. ...Vardenaf
Vardenafil in the Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis.
Wang H, Guo B, Huang Z, Zhao X, Ji Z. Wang H, et al. Adv Ther. 2021 Feb;38(2):1301-1313. doi: 10.1007/s12325-020-01559-9. Epub 2021 Jan 11. Adv Ther. 2021. PMID: 33432539
INTRODUCTION: We carried out this systemic review and meta-analysis of relevant randomized controlled trials to determine different dosage regimens of vardenafil in the treatment of male erectile dysfunction (ED). METHODS: Using appropriate keywords, we searched PubMed, th …
INTRODUCTION: We carried out this systemic review and meta-analysis of relevant randomized controlled trials to determine different dosage r …
Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study.
Jing ZC, Yu ZX, Shen JY, Wu BX, Xu KF, Zhu XY, Pan L, Zhang ZL, Liu XQ, Zhang YS, Jiang X, Galiè N; Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Jing ZC, et al. Am J Respir Crit Care Med. 2011 Jun 15;183(12):1723-9. doi: 10.1164/rccm.201101-0093OC. Epub 2011 Mar 11. Am J Respir Crit Care Med. 2011. PMID: 21471085 Clinical Trial.
Vardenafil was associated with only mild and transient adverse events. CONCLUSIONS: Vardenafil is effective and well tolerated in patients with PAH at a dose of 5 mg twice daily....
Vardenafil was associated with only mild and transient adverse events. CONCLUSIONS: Vardenafil is effective and well tolerated
Vardenafil in patients with erectile dysfunction: achieving treatment optimization.
Hellstrom WJ, Elhilali M, Homering M, Taylor T, Gittleman M. Hellstrom WJ, et al. J Androl. 2005 Sep-Oct;26(5):604-9. doi: 10.2164/jandrol.05026. J Androl. 2005. PMID: 16088037 Free article. Clinical Trial.
For the first attempt, the probability of achieving successful penetration was higher in all 3 vardenafil groups compared with placebo; 67% in the 5-mg vardenafil group, 77% in the 10-mg vardenafil group, and 74% in the 20-mg vardenafil group compared …
For the first attempt, the probability of achieving successful penetration was higher in all 3 vardenafil groups compared with placeb …
Pharmacokinetics comparison of vardenafil as administered by an intranasal spray formulation vs a 10-mg oral tablet.
Wang J, Chow SL, Chow MSS, Paik A, Louie SG, Dong F, Sathananthan A, White S. Wang J, et al. J Sex Med. 2023 Jun 28;20(7):1004-1009. doi: 10.1093/jsxmed/qdad056. J Sex Med. 2023. PMID: 37147929 Clinical Trial.
BACKGROUND: Oral vardenafil (VDF) tablet is an effective treatment for erectile dysfunction (ED), but intranasal administration with a suitable formulation can lead to a faster onset of action and offer more convenient planning for ED treatment. ...
BACKGROUND: Oral vardenafil (VDF) tablet is an effective treatment for erectile dysfunction (ED), but intranasal administration with …
Phosphodiesterase 5 inhibitors for pulmonary hypertension.
Barnes H, Brown Z, Burns A, Williams T. Barnes H, et al. Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD012621. doi: 10.1002/14651858.CD012621.pub2. Cochrane Database Syst Rev. 2019. PMID: 30701543 Free PMC article.
AUTHORS' CONCLUSIONS: PDE5 inhibitors appear to have clear beneficial effects in group 1 PAH. Sildenafil, tadalafil and vardenafil are all efficacious in this clinical setting, and clinicians should consider the side-effect profile for each individual when choosing which P …
AUTHORS' CONCLUSIONS: PDE5 inhibitors appear to have clear beneficial effects in group 1 PAH. Sildenafil, tadalafil and vardenafil ar …
Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
Ishii N, Nagao K, Fujikawa K, Tachibana T, Iwamoto Y, Kamidono S. Ishii N, et al. Int J Urol. 2006 Aug;13(8):1066-72. doi: 10.1111/j.1442-2042.2006.01480.x. Int J Urol. 2006. PMID: 16903931 Clinical Trial.
AIM: Vardenafil is a highly selective and potent phosphodiesterase type-5 inhibitor for the treatment of erectile dysfunction (ED). ...CONCLUSION: In Japanese men with DM and ED, vardenafil 10 mg and 20 mg were effective in improving erectile function with comparabl …
AIM: Vardenafil is a highly selective and potent phosphodiesterase type-5 inhibitor for the treatment of erectile dysfunction (ED). . …
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wachs BH; Vardenafil Study Group. Giuliano F, et al. Spine (Phila Pa 1976). 2008 Apr 1;33(7):709-15. doi: 10.1097/BRS.0b013e3181695040. Spine (Phila Pa 1976). 2008. PMID: 18379396 Clinical Trial.

Significant improvements in confidence scores were observed with vardenafil compared with placebo (P < 0.0001). There were no clinically significant differences between vardenafil and placebo in the quality-of-life measures at the study endpoint, but these had be

Significant improvements in confidence scores were observed with vardenafil compared with placebo (P < 0.0001). There were no clin

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study.
Klotz T, Sachse R, Heidrich A, Jockenhövel F, Rohde G, Wensing G, Horstmann R, Engelmann R. Klotz T, et al. World J Urol. 2001 Feb;19(1):32-9. doi: 10.1007/s003450000168. World J Urol. 2001. PMID: 11289568 Clinical Trial.
For the 20-mg dose, the increase in duration of > 60% penile rigidity relative to placebo was 37.2 min (20.2 to 54.1) at the base and 28.7 min (12.7 to 44.7) at the tip. Single doses of 10 and 20 mg vardenafil led to a rapid rise in the plasma concentrations of varde
For the 20-mg dose, the increase in duration of > 60% penile rigidity relative to placebo was 37.2 min (20.2 to 54.1) at the base and 28. …
147 results